ArticlePloS one2026
IGM: Integrated Gene-expression Modeling for multi-condition flux-preserving genome-scale metabolic models.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genome-scale metabolic models (GEMs) are powerful tools for studying cellular metabolism, but conventional approaches such as Flux Balance Analysis (FBA) often yield ambiguous results due to the lack of consistent integration of condition-specific data across multiple experimental contexts. Existing methods for incorporating gene expression data into GEMs are typically limited to single-condition analyses, rely on arbitrary thresholds, or compromise the interpretability of flux predictions. Here, we present IGM: Integrated Gene-expression Modeling, a novel mixed-integer linear programming (MILP) framework that integrates gene expression data across multiple conditions into GEMs without binarization, thereby preserving flux units and enhancing biological relevance. IGM employs flux variability analysis (FVA) to define feasible flux ranges, integrates relative gene expression through gene-protein-reaction (GPR) rules, and minimizes the difference between fluxes and corresponding gene expression mappings. Evaluation on Escherichia coli (E. coli) metabolic models demonstrates that IGM significantly improves correlation with experimentally measured fluxes, reduces flux solution ambiguity, and provides higher predictive consistency across multiple conditions. Among its variants, IGM with L1 norm regularization achieves the highest accuracy. We also evaluated gene expression integration by comparing relative gene expression values with model-derived gene expression variables. Visual inspection and genome-scale correlation analysis revealed strong concordance across all genes, confirming that IGM effectively preserves transcriptomic patterns while filtering out genes irrelevant to flux-carrying reactions, thereby enhancing biological interpretability. Furthermore, we applied IGM to flux change analysis, where subsystem-level fluxes revealed distinct metabolic states. This analysis highlights IGM's ability to integrate transcriptomic data into metabolic modeling in a condition-specific yet consistent manner, enabling biologically grounded predictions of metabolic adaptation. By capturing dynamic metabolic changes and improving predictive accuracy, IGM provides a robust framework for consistent, comparative, and multi-condition metabolic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.